nodes	percent_of_prediction	percent_of_DWPC	metapath
Brimonidine—Erythema facial—Hydroxyurea—head and neck cancer	0.0848	0.0861	CcSEcCtD
Brimonidine—Common cold—Fluorouracil—head and neck cancer	0.0427	0.0434	CcSEcCtD
Brimonidine—Scab—Fluorouracil—head and neck cancer	0.035	0.0356	CcSEcCtD
Brimonidine—Allergic contact dermatitis—Fluorouracil—head and neck cancer	0.0319	0.0324	CcSEcCtD
Brimonidine—Gastrointestinal symptom NOS—Hydroxyurea—head and neck cancer	0.0263	0.0267	CcSEcCtD
Brimonidine—Skin irritation—Fluorouracil—head and neck cancer	0.0258	0.0262	CcSEcCtD
Brimonidine—Blepharitis—Hydroxyurea—head and neck cancer	0.0252	0.0256	CcSEcCtD
Brimonidine—Gastrointestinal symptom NOS—Fluorouracil—head and neck cancer	0.019	0.0192	CcSEcCtD
Brimonidine—Lacrimation—Fluorouracil—head and neck cancer	0.019	0.0192	CcSEcCtD
Brimonidine—Blepharitis—Fluorouracil—head and neck cancer	0.0181	0.0184	CcSEcCtD
Brimonidine—Photophobia—Vinblastine—head and neck cancer	0.0159	0.0162	CcSEcCtD
Brimonidine—Clonidine—CYP1A1—head and neck cancer	0.0153	1	CrCbGaD
Brimonidine—Stinging—Fluorouracil—head and neck cancer	0.0138	0.014	CcSEcCtD
Brimonidine—Lacrimation—Docetaxel—head and neck cancer	0.0137	0.0139	CcSEcCtD
Brimonidine—Eye irritation—Fluorouracil—head and neck cancer	0.0131	0.0133	CcSEcCtD
Brimonidine—Lacrimation increased—Fluorouracil—head and neck cancer	0.0121	0.0123	CcSEcCtD
Brimonidine—Burning sensation—Docetaxel—head and neck cancer	0.0116	0.0118	CcSEcCtD
Brimonidine—Dermatitis contact—Fluorouracil—head and neck cancer	0.011	0.0112	CcSEcCtD
Brimonidine—Face oedema—Hydroxyurea—head and neck cancer	0.0109	0.011	CcSEcCtD
Brimonidine—Scotoma—Docetaxel—head and neck cancer	0.0106	0.0108	CcSEcCtD
Brimonidine—Photophobia—Fluorouracil—head and neck cancer	0.0105	0.0106	CcSEcCtD
Brimonidine—Coma—Fluorouracil—head and neck cancer	0.0102	0.0103	CcSEcCtD
Brimonidine—Depression—Vinblastine—head and neck cancer	0.00947	0.00962	CcSEcCtD
Brimonidine—Eye irritation—Docetaxel—head and neck cancer	0.00942	0.00957	CcSEcCtD
Brimonidine—Swelling—Fluorouracil—head and neck cancer	0.00917	0.00931	CcSEcCtD
Brimonidine—Lacrimation increased—Docetaxel—head and neck cancer	0.00873	0.00886	CcSEcCtD
Brimonidine—Drowsiness—Hydroxyurea—head and neck cancer	0.00866	0.0088	CcSEcCtD
Brimonidine—Pharyngitis—Vinblastine—head and neck cancer	0.00846	0.00859	CcSEcCtD
Brimonidine—Lethargy—Fluorouracil—head and neck cancer	0.00826	0.00838	CcSEcCtD
Brimonidine—Respiratory failure—Docetaxel—head and neck cancer	0.00819	0.00832	CcSEcCtD
Brimonidine—Osteoarthritis—Fluorouracil—head and neck cancer	0.00809	0.00822	CcSEcCtD
Brimonidine—Dry skin—Fluorouracil—head and neck cancer	0.00742	0.00753	CcSEcCtD
Brimonidine—Nasopharyngitis—Fluorouracil—head and neck cancer	0.00723	0.00735	CcSEcCtD
Brimonidine—Angiopathy—Hydroxyurea—head and neck cancer	0.00705	0.00716	CcSEcCtD
Brimonidine—Erythema—Hydroxyurea—head and neck cancer	0.00677	0.00687	CcSEcCtD
Brimonidine—Swelling—Docetaxel—head and neck cancer	0.00662	0.00672	CcSEcCtD
Brimonidine—Hypertension—Vinblastine—head and neck cancer	0.00641	0.00651	CcSEcCtD
Brimonidine—Discomfort—Vinblastine—head and neck cancer	0.00624	0.00634	CcSEcCtD
Brimonidine—Visual disturbance—Docetaxel—head and neck cancer	0.00616	0.00626	CcSEcCtD
Brimonidine—Conjunctivitis—Fluorouracil—head and neck cancer	0.00606	0.00615	CcSEcCtD
Brimonidine—Lethargy—Docetaxel—head and neck cancer	0.00596	0.00605	CcSEcCtD
Brimonidine—Sinusitis—Fluorouracil—head and neck cancer	0.00585	0.00594	CcSEcCtD
Brimonidine—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00572	0.00581	CcSEcCtD
Brimonidine—Discomfort—Hydroxyurea—head and neck cancer	0.00569	0.00578	CcSEcCtD
Brimonidine—Rhinitis—Fluorouracil—head and neck cancer	0.00561	0.0057	CcSEcCtD
Brimonidine—Pharyngitis—Fluorouracil—head and neck cancer	0.00555	0.00564	CcSEcCtD
Brimonidine—Oedema—Hydroxyurea—head and neck cancer	0.00552	0.00561	CcSEcCtD
Brimonidine—Infection—Hydroxyurea—head and neck cancer	0.00549	0.00557	CcSEcCtD
Brimonidine—Paraesthesia—Vinblastine—head and neck cancer	0.00544	0.00552	CcSEcCtD
Brimonidine—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00542	0.0055	CcSEcCtD
Brimonidine—Skin disorder—Hydroxyurea—head and neck cancer	0.00537	0.00545	CcSEcCtD
Brimonidine—Dry skin—Docetaxel—head and neck cancer	0.00535	0.00544	CcSEcCtD
Brimonidine—Nasopharyngitis—Docetaxel—head and neck cancer	0.00522	0.0053	CcSEcCtD
Brimonidine—Pain—Vinblastine—head and neck cancer	0.00518	0.00526	CcSEcCtD
Brimonidine—Arrhythmia—Fluorouracil—head and neck cancer	0.005	0.00508	CcSEcCtD
Brimonidine—Dyspnoea—Hydroxyurea—head and neck cancer	0.00492	0.005	CcSEcCtD
Brimonidine—Somnolence—Hydroxyurea—head and neck cancer	0.00491	0.00499	CcSEcCtD
Brimonidine—Erythema—Fluorouracil—head and neck cancer	0.00487	0.00495	CcSEcCtD
Brimonidine—Dyspepsia—Hydroxyurea—head and neck cancer	0.00486	0.00494	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00477	0.00484	CcSEcCtD
Brimonidine—Fatigue—Hydroxyurea—head and neck cancer	0.00476	0.00484	CcSEcCtD
Brimonidine—Pain—Hydroxyurea—head and neck cancer	0.00472	0.0048	CcSEcCtD
Brimonidine—Vision blurred—Fluorouracil—head and neck cancer	0.00459	0.00466	CcSEcCtD
Brimonidine—Hypersensitivity—Vinblastine—head and neck cancer	0.00446	0.00453	CcSEcCtD
Brimonidine—Conjunctivitis—Docetaxel—head and neck cancer	0.00437	0.00444	CcSEcCtD
Brimonidine—Asthenia—Vinblastine—head and neck cancer	0.00435	0.00441	CcSEcCtD
Brimonidine—Chest pain—Fluorouracil—head and neck cancer	0.00415	0.00421	CcSEcCtD
Brimonidine—Myalgia—Fluorouracil—head and neck cancer	0.00415	0.00421	CcSEcCtD
Brimonidine—Discomfort—Fluorouracil—head and neck cancer	0.0041	0.00416	CcSEcCtD
Brimonidine—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00407	0.00413	CcSEcCtD
Brimonidine—Rhinitis—Docetaxel—head and neck cancer	0.00405	0.00411	CcSEcCtD
Brimonidine—Pharyngitis—Docetaxel—head and neck cancer	0.00401	0.00407	CcSEcCtD
Brimonidine—Dizziness—Vinblastine—head and neck cancer	0.00401	0.00407	CcSEcCtD
Brimonidine—Oedema—Fluorouracil—head and neck cancer	0.00398	0.00404	CcSEcCtD
Brimonidine—Asthenia—Hydroxyurea—head and neck cancer	0.00396	0.00402	CcSEcCtD
Brimonidine—Infection—Fluorouracil—head and neck cancer	0.00395	0.00401	CcSEcCtD
Brimonidine—Nervous system disorder—Fluorouracil—head and neck cancer	0.0039	0.00396	CcSEcCtD
Brimonidine—Visual impairment—Docetaxel—head and neck cancer	0.00389	0.00395	CcSEcCtD
Brimonidine—Tachycardia—Fluorouracil—head and neck cancer	0.00388	0.00394	CcSEcCtD
Brimonidine—Headache—Vinblastine—head and neck cancer	0.00379	0.00385	CcSEcCtD
Brimonidine—Eye disorder—Docetaxel—head and neck cancer	0.00377	0.00383	CcSEcCtD
Brimonidine—Flushing—Docetaxel—head and neck cancer	0.00375	0.00381	CcSEcCtD
Brimonidine—Cardiac disorder—Docetaxel—head and neck cancer	0.00375	0.00381	CcSEcCtD
Brimonidine—Hypotension—Fluorouracil—head and neck cancer	0.00372	0.00377	CcSEcCtD
Brimonidine—Angiopathy—Docetaxel—head and neck cancer	0.00366	0.00372	CcSEcCtD
Brimonidine—Dizziness—Hydroxyurea—head and neck cancer	0.00365	0.00371	CcSEcCtD
Brimonidine—Immune system disorder—Docetaxel—head and neck cancer	0.00365	0.00371	CcSEcCtD
Brimonidine—Mediastinal disorder—Docetaxel—head and neck cancer	0.00364	0.0037	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.00362	0.00368	CcSEcCtD
Brimonidine—Arrhythmia—Docetaxel—head and neck cancer	0.00361	0.00366	CcSEcCtD
Brimonidine—Nausea—Vinblastine—head and neck cancer	0.0036	0.00365	CcSEcCtD
Brimonidine—Insomnia—Fluorouracil—head and neck cancer	0.0036	0.00365	CcSEcCtD
Brimonidine—Paraesthesia—Fluorouracil—head and neck cancer	0.00357	0.00363	CcSEcCtD
Brimonidine—Dyspnoea—Fluorouracil—head and neck cancer	0.00354	0.0036	CcSEcCtD
Brimonidine—Mental disorder—Docetaxel—head and neck cancer	0.00354	0.00359	CcSEcCtD
Brimonidine—Somnolence—Fluorouracil—head and neck cancer	0.00353	0.00359	CcSEcCtD
Brimonidine—Erythema—Docetaxel—head and neck cancer	0.00352	0.00357	CcSEcCtD
Brimonidine—Dyspepsia—Fluorouracil—head and neck cancer	0.0035	0.00355	CcSEcCtD
Brimonidine—Rash—Hydroxyurea—head and neck cancer	0.00348	0.00354	CcSEcCtD
Brimonidine—Dermatitis—Hydroxyurea—head and neck cancer	0.00348	0.00353	CcSEcCtD
Brimonidine—Headache—Hydroxyurea—head and neck cancer	0.00346	0.00351	CcSEcCtD
Brimonidine—Dysgeusia—Docetaxel—head and neck cancer	0.00344	0.0035	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.00343	0.00349	CcSEcCtD
Brimonidine—Pain—Fluorouracil—head and neck cancer	0.0034	0.00345	CcSEcCtD
Brimonidine—Nausea—Hydroxyurea—head and neck cancer	0.00328	0.00333	CcSEcCtD
Brimonidine—Syncope—Docetaxel—head and neck cancer	0.00315	0.0032	CcSEcCtD
Brimonidine—Palpitations—Docetaxel—head and neck cancer	0.00311	0.00316	CcSEcCtD
Brimonidine—Loss of consciousness—Docetaxel—head and neck cancer	0.00309	0.00314	CcSEcCtD
Brimonidine—Cough—Docetaxel—head and neck cancer	0.00307	0.00312	CcSEcCtD
Brimonidine—Hypertension—Docetaxel—head and neck cancer	0.00304	0.00308	CcSEcCtD
Brimonidine—Arthralgia—Docetaxel—head and neck cancer	0.00299	0.00304	CcSEcCtD
Brimonidine—Myalgia—Docetaxel—head and neck cancer	0.00299	0.00304	CcSEcCtD
Brimonidine—Chest pain—Docetaxel—head and neck cancer	0.00299	0.00304	CcSEcCtD
Brimonidine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.00297	0.00302	CcSEcCtD
Brimonidine—Hypersensitivity—Fluorouracil—head and neck cancer	0.00293	0.00298	CcSEcCtD
Brimonidine—Dry mouth—Docetaxel—head and neck cancer	0.00293	0.00297	CcSEcCtD
Brimonidine—Oedema—Docetaxel—head and neck cancer	0.00287	0.00291	CcSEcCtD
Brimonidine—Infection—Docetaxel—head and neck cancer	0.00285	0.0029	CcSEcCtD
Brimonidine—Shock—Docetaxel—head and neck cancer	0.00282	0.00287	CcSEcCtD
Brimonidine—Nervous system disorder—Docetaxel—head and neck cancer	0.00281	0.00286	CcSEcCtD
Brimonidine—Pruritus—Fluorouracil—head and neck cancer	0.00281	0.00286	CcSEcCtD
Brimonidine—Tachycardia—Docetaxel—head and neck cancer	0.0028	0.00284	CcSEcCtD
Brimonidine—Skin disorder—Docetaxel—head and neck cancer	0.00279	0.00283	CcSEcCtD
Brimonidine—Hypotension—Docetaxel—head and neck cancer	0.00268	0.00272	CcSEcCtD
Brimonidine—Dizziness—Fluorouracil—head and neck cancer	0.00263	0.00267	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.00261	0.00266	CcSEcCtD
Brimonidine—Insomnia—Docetaxel—head and neck cancer	0.0026	0.00264	CcSEcCtD
Brimonidine—Paraesthesia—Docetaxel—head and neck cancer	0.00258	0.00262	CcSEcCtD
Brimonidine—Dyspnoea—Docetaxel—head and neck cancer	0.00256	0.0026	CcSEcCtD
Brimonidine—Somnolence—Docetaxel—head and neck cancer	0.00255	0.00259	CcSEcCtD
Brimonidine—Dyspepsia—Docetaxel—head and neck cancer	0.00253	0.00257	CcSEcCtD
Brimonidine—Rash—Fluorouracil—head and neck cancer	0.00251	0.00255	CcSEcCtD
Brimonidine—Dermatitis—Fluorouracil—head and neck cancer	0.0025	0.00254	CcSEcCtD
Brimonidine—Headache—Fluorouracil—head and neck cancer	0.00249	0.00253	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.00248	0.00252	CcSEcCtD
Brimonidine—Fatigue—Docetaxel—head and neck cancer	0.00247	0.00251	CcSEcCtD
Brimonidine—Pain—Docetaxel—head and neck cancer	0.00245	0.00249	CcSEcCtD
Brimonidine—Nausea—Fluorouracil—head and neck cancer	0.00236	0.0024	CcSEcCtD
Brimonidine—Hypersensitivity—Docetaxel—head and neck cancer	0.00211	0.00215	CcSEcCtD
Brimonidine—Asthenia—Docetaxel—head and neck cancer	0.00206	0.00209	CcSEcCtD
Brimonidine—Pruritus—Docetaxel—head and neck cancer	0.00203	0.00206	CcSEcCtD
Brimonidine—Dizziness—Docetaxel—head and neck cancer	0.0019	0.00193	CcSEcCtD
Brimonidine—Rash—Docetaxel—head and neck cancer	0.00181	0.00184	CcSEcCtD
Brimonidine—Dermatitis—Docetaxel—head and neck cancer	0.00181	0.00184	CcSEcCtD
Brimonidine—Headache—Docetaxel—head and neck cancer	0.0018	0.00183	CcSEcCtD
Brimonidine—Nausea—Docetaxel—head and neck cancer	0.0017	0.00173	CcSEcCtD
